Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in VCEL — Vericel Corp

CIK 1446194 BALA CYNWYD, PA
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$639,365
-$168,102 QoQ
Shares Held
14,371
-42.7% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#165
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Derivatives in VCEL

reported options exposure · as of Jun 30, 2026
CallValue
$1,072,209
CallShares
24,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. VCEL ranks #151 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in VCEL

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,072,209 24,100
2026-06-30 $639,365 14,371
2026-03-31 $807,467 25,100
2026-03-31 $18,439,844 573,200
2026-03-31 $18,481,665 574,500
2025-12-31 $731,003 20,300
2025-12-31 $216,060 6,000
2025-09-30 $215,317 6,842
2025-09-30 $223,437 7,100
2025-09-30 $286,377 9,100
2025-06-30 $2,657,630 62,459
2025-06-30 $633,995 14,900
2025-06-30 $327,635 7,700
2025-03-31 $414,966 9,300
2025-03-31 $3,107,872 69,652
2024-12-31 $1,380,711 25,145
2024-12-31 $1,559,444 28,400
2024-12-31 $2,877,284 52,400
2024-09-30 $912,600 21,600
2024-09-30 $299,975 7,100
2024-09-30 $1,441,189 34,111
2024-06-30 $1,057,671 23,053
2024-06-30 $2,316,940 50,500
2024-03-31 $4,473,720 86,000
2024-03-31 $2,126,317 40,875
2024-03-31 $2,731,050 52,500
2023-12-31 $313,368 8,800
2023-12-31 $897,372 25,200
2023-12-31 $644,576 18,101
2023-09-30 $278,216 8,300
2023-09-30 $586,600 17,500
2023-09-30 $2,408,980 71,867
2023-06-30 $2,209,265 58,804
2023-06-30 $202,878 5,400
2023-06-30 $961,792 25,600
2023-03-31 $240,424 8,200
2023-03-31 $750,592 25,600
2023-03-31 $2,465,459 84,088
2022-12-31 $369,523 14,029
2022-12-31 $455,682 17,300
2022-09-30 $334,080 14,400
2022-09-30 $1,234,936 53,230
2022-06-30 $711,335 28,250
2022-06-30 $2,246,056 89,200
2022-03-31 $2,046,795 53,553
2022-03-31 $970,788 25,400
2022-03-31 $791,154 20,700
2021-12-31 $1,937,490 49,300
2021-12-31 $491,250 12,500
2021-12-31 $2,134,225 54,306